MILPHARM LIMITED — Sitagliptin Importer Profile
Pharmaceutical Importer · #19 buyer for Sitagliptin · $945.8K import value · 26 shipments · UNITED KINGDOM · DGFT Verified
MILPHARM LIMITED is the #19 importer of Sitagliptin from India with $945.8K in import value and 26 verified shipments. MILPHARM LIMITED holds a 0.7% market share in Sitagliptin imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 22 formulations shipped to 1 country. Overall, MILPHARM LIMITED imports 8 pharmaceutical products worth $8.2M across 6 therapeutic categories.
MILPHARM LIMITED — Sitagliptin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sitagliptin to MILPHARM LIMITED?
Verified from 26 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| AUROBINDO PHARMA LIMITED | $945.8K | 26 | 100.0% |
MILPHARM LIMITED sources Sitagliptin from 1 verified Indian supplier based on 26 customs records. The primary supplier is AUROBINDO PHARMA LIMITED accounting for 100.0% of imports.
How Does MILPHARM LIMITED Compare to Nearest Sitagliptin Importers?
Buyers ranked immediately above and below #19 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 14 | ESQUIVEL JIMAREZ SERGIO DOMICILIO C PINOS | MEXICO | $1.0M | 20 | $50.0K |
| 9 | XXAROXXPHAXXA SXX DXXC VX | MEXICO | $600.0K | 12 | $50.0K |
| 19 | MILPHARM LIMITED ★ | UNITED KINGDOM | $550.0K | 11 | $50.0K |
| 18 | CSP MYLAN SAS AT CSP LABO 274 | FRANCE | $500.0K | 10 | $50.0K |
MILPHARM LIMITED ranks #19 among 575 Sitagliptin importers from India. Average shipment value of $50.0K compared to the market average of $44.6K. The closest competitors by value are ESQUIVEL JIMAREZ SERGIO DOMICILIO C PINOS and XXAROXXPHAXXA SXX DXXC VX.
Where Does MILPHARM LIMITED Import Sitagliptin To?
Destination countries from 26 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $945.8K | 26 | 100.0% |
MILPHARM LIMITED imports Sitagliptin to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $945.8K.
What Sitagliptin Formulations Does MILPHARM LIMITED Import?
| Formulation | Value | Shipments |
|---|---|---|
| SITAGLIPTIN TABLETS 100MG (SITAGLIPTIN 1 | $100.0K | 2 |
| SITAGLIPTIN TABLETS 100MG, 33120 PACKS O | $100.0K | 2 |
| SITAGLIPTIN TABLETS 100 MGSITAGLIPTIN 100MG FILM-COATED TABLETS 28'S QTY:33157 PAK | $100.0K | 2 |
| SITAGLIPTIN TABLETS 100 MG (SITAGLIPTIN100MG FILM-COATED TABLETS) 28'S | $100.0K | 2 |
| SITAGLIPTIN TABLETS 100MG 22032 PACKS OF 28'S AS PER DOCUMENT | $50.0K | 1 |
| SITAGLIPTIN TABLETS 100 MG(SITAGLIPTIN 100MG FILM-COATED TABLETS)28 S(33120 PAK) | $50.0K | 1 |
| SITAGLIPTIN TABLETS 100 MG(SITAGLIPTIN 100MG FILM-COATED TABLETS)28 S(65952 PAKS) | $50.0K | 1 |
| SITAGLIPTIN TABLETS 100MG, 54351 PACKS O | $50.0K | 1 |
| SITAGLIPTIN TABLETS 100 MG SITAGLIPTIN100MG FILM-COATED TABLETS 28S QTY:66026PAK | $50.0K | 1 |
| SITAGLIPTIN TABLETS 50 MG (SITAGLIPTIN 50MG FILM-COATED TABLETS) 28'S (QTY: 28711 PAK) | $41.3K | 1 |
MILPHARM LIMITED imports 22 distinct Sitagliptin formulations from India. The top formulation is SITAGLIPTIN TABLETS 100MG (SITAGLIPTIN 1 with 2 shipments worth $100.0K.
Regulatory Requirements: Importing Sitagliptin into United Kingdom
What MILPHARM LIMITED and other importers must comply with to import Sitagliptin from India
Regulatory Authority
Medicines and Healthcare products Regulatory Agency (MHRA)
Approval Process for Generic Sitagliptin
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
GMP Requirements
UK GMP compliance; MHRA GMP inspection of manufacturing site
Import Licence & Documentation
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
Labeling & Packaging
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Sitagliptin from India and How Much Does MILPHARM LIMITED Import?
India exported $25.7M worth of Sitagliptin through 5,364 shipments from 309 suppliers to 121 countries, serving 575 buyers globally. MILPHARM LIMITED imports $945.8K of this total, accounting for 0.7% of India's Sitagliptin exports with 26 shipments from UNITED KINGDOM. This is verified from 26 customs shipment records covering 22 distinct formulations.
What Is the Average Order Value for MILPHARM LIMITED's Sitagliptin Imports?
MILPHARM LIMITED's average Sitagliptin order value is $36.4K per consignment, based on 26 shipments totaling $945.8K. MILPHARM LIMITED is based in UNITED KINGDOM and ranks #19 among all Sitagliptin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Sitagliptin to MILPHARM LIMITED?
MILPHARM LIMITED sources Sitagliptin from 1 verified Indian supplier: AUROBINDO PHARMA LIMITED ($945.8K, 100.0%). This is based on 26 customs records.
How Does MILPHARM LIMITED Compare to Other Sitagliptin Importers?
MILPHARM LIMITED ranks #19 among 575 Sitagliptin importers from India with a 0.7% market share. The top 3 importers are NEXT PHARMA LOGISTICS GMBH ($4.3M), SUDAIR PHARMA COMPANY ($3.2M), SANDOZ CANADA INC. C/O UPS SCS ($3.0M). MILPHARM LIMITED processed 26 shipments from UNITED KINGDOM.
About MILPHARM LIMITED
MILPHARM LIMITED imports 8 products worth $8.2M. Beyond Sitagliptin, top products include Ramipril, Gabapentin, Clarithromycin, Propranolol, Isosorbide. View the complete MILPHARM LIMITED profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sitagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: MILPHARM LIMITED matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as MILPHARM LIMITED's capped import value divided by total capped export value for Sitagliptin across all Indian exporters.
- 5.Verified Records: This page is backed by 26 individual customs records matching MILPHARM LIMITED importing Sitagliptin, covering 22 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 575+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sitagliptin Import Data for MILPHARM LIMITED
Access order-level details, pricing data, supplier connections, and competitive analysis for MILPHARM LIMITED's Sitagliptin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MILPHARM LIMITED
Full Company Profile →
8 products · $8.2M total trade · 6 categories
MILPHARM LIMITED × Sitagliptin
Verified from customs records
Company Overview
Top Products by MILPHARM LIMITED
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for MILPHARM LIMITED.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sitagliptin. For current order-level data, contact TransData Nexus.